Home
Apollon Formularies PLC

Apollon Formularies PLC Market Share Analysis for June 2026

International medical cannabis pharmaceutical company specialising in cutting edge research and treatment of patients with cancer and chronic pain.

Industry: N/A

Domainapollon.org.uk

Year Founded2014

Employees51 - 200

Annual Revenue--

Apollon Formularies PLC

Apollon Formularies PLC (including company regionals)

apollon.org.uk

See more website traffic and engagement information

Total visits to Apollon Formularies PLC's top domains

Understand Apollon Formularies PLC market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

apollon.org.uk334

See more with Sales Intelligence

Avg. visit duration in Apollon Formularies PLC's top domains

Analyze Apollon Formularies PLC engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

apollon.org.uk--

See more with Sales Intelligence

Avg. pageviews on Apollon Formularies PLC's top domains

See how Apollon Formularies PLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

apollon.org.uk1.14

See more with Sales Intelligence

Apollon Formularies PLC top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Apollon Formularies PLC

These are the website technologies, by industry, used by Apollon Formularies PLC top domains

Advertising (3)

Google Adsense

Social (3)

Google+ Platform

Widget (3)

reCAPTCHA

Audio Video Media (2)

YouTube

More Technologies

8

See all

News & Signals from Apollon Formularies PLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsApollon Formularies PLC sold assets to Sproutly Inc. on Sep 12th '23.Under the terms of the binding LOI dated September 12, 2023, after the successful completion of due diligence as described below, Sproutly will acquire the assets of Apollon pursuant to an Asset Purchase Agreement.

NewsApollon Formularies PLC sold assets to Global Hemp in the amount of $250K on Sep 1st '23.The Company has also been granted a 60-day option to conduct due diligence, following which GHG may exercise its option to acquire the entirety of Apollon's global assets.